CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 545	$ 42
Operating expenses:
Research and development	12,013	2,209
Selling, general, and administrative	6,985	2,296
Total operating expenses	18,998	4,505
Loss from operations	(18,453)	(4,463)
Royalty liability interest expense - related parties	(8,329)	0
Other interest income (expense), net	193	(21)
Non-operating income (expense)	(369)	(910)
Loss before income taxes	(26,958)	(5,394)
Income tax expense	(14)	0
Net loss	(26,972)	(5,394)
Net loss attributable to redeemable noncontrolling interest	(3,537)	0
Net loss attributable to Cibus, Inc.	$ (23,435)	$ (5,394)
Basic net loss per share of Class A common stock (in dollars per share)	$ (1.12)	$ (5.46)
Diluted net loss per share of Class A common stock (in dollars per share)	$ (1.12)	$ (5.46)
Weighted average shares of Class A common stock outstanding - basic (in shares)	20,862,938	988,145
Weighted average shares of Class A common stock outstanding - diluted (in shares)	20,862,938	988,145